STOCKS TELEGRAPH

Tag: CHEK

  • Check-Cap Ltd. (CHEK) Stock Plunging Deep in Early Trading as it Announces Registered Direct Offering.

    Check-Cap Ltd. (CHEK) is a late-clinical stage company redefining the screening of colorectal cancer via the introduction of C-Scan. It is the pioneer screening test for the detection of polyps long before they transform into CRC. Its capsule-based screening technology significantly increases screening devotion globally. C-Scan uses an X-ray capsule of ultra-low-dose along with exclusive software for the generation of a 3D map of the internal colon lining.

    The price of CHEK stock during the early trading on March 1, 2022, was last checked to be $0.41 with a fall of 32.58%.

    CHEK: Events and Happenings

    On March 1, 2022, CHEK reported its entry into definitive contracts with several investors for the acquisition and sale of 20,000,000 of its ordinary shares and warrants to acquire up to 15,000,000 ordinary shares. Each ordinary share and warrant are sold to acquire 0.75 ordinary shares at a joint offering price of $0.50 per share and warrant. The offering is anticipated to close on March 3, 2022.

    On February 7, 2022, CHEK updated on the approval receipt for its altered IDE application by the FDA. The approval enabled the company to start the pivotal study. On December 23, 2021, CHEK was informed about the receipt of notification from the NASDAQ regarding non-compliance with the least bid price obligation for the continued listing to retain a least per share price of $1.00.

    On November 22, 2021, CHEK announced the publication of its research in the peer-reviewed Digestive Diseases and Sciences journal. The title of the research is ‘Colorectal cancer and polyp detection using a new preparation-free colon-scan capsule: A pilot study of safety and patient satisfaction.’

    CHEK: Key Financials

    On November 3, 2021, CHEK released its financial results for the third quarter of 2021 ended September 30, 2021. Some of the main highlights are discussed below.

    Revenue

    No revenue was recorded in the third quarter of 2021 like in the same quarter of 2020.

    EPS

    Basic and diluted net loss per share in Q3 2021 was $4.2 million or $0.15 against $3.6 million or $0.40 in the same quarter in 2020. The company observed a rise in its EPS over the year. The company also topped the EPS estimates by $0.01.

    Conclusion

    CHEK stock is approximately 20% up the last year which showed the devotedness of its team in the pandemic. In Tuesday’s early trading session, the company’s stock sank as a consequence of a registered direct offering announcement. For the fourth quarter of 2021, the company expects an EPS of -$0.04.

  • Check-Cap Ltd. (CHEK) Stock Plummets Following News of Registered Direct Offering

    Check-Cap Ltd. (CHEK) Stock Plummets Following News of Registered Direct Offering

    Check-Cap Ltd. (CHEK) stock prices were down by 19.5364% some time after market trading commenced on June 30th, 2021, bringing the price per share down to USD$1.2150 early on in the trading day.

    Registered Direct Offering

    The company announced on June 30th, 2021 that it had entered into various definitive agreements with institutional and accredited investors. As per the agreement, the company would put up 25,925,926 ordinary shares of the company for sale, along with warrants to purchase up to the same number of ordinary shares. The registered direct offering is seeing each ordinary share being sold in conjunction with one short-term warrant to purchase one ordinary share at a combined offering price price of USD$1.35 per ordinary share and accompanying warrant.

    Share Warrants

    The short-term warrants will have an expiry date of two and a half years following the date of issuance and will be exercisable immediately with an exercise price of USD$1.50 per ordinary share. The closing of the registered direct offering is expected to close on July 2nd, 2021, pending the satisfaction of customary closing conditions.

    Capital Generation

    CHEK forecasts generating roughly USD$35 million in gross proceeds from the offering, before the deduction of expenses related to the offering. This number does not include proceeds received from the exercising of warrants, the full exercising of which will generate additional gross proceeds of roughly USD$38.9 million before the deduction of offering-related expenses. The capital generated from the offering is planned on being allocated towards advancing the ongoing clinical development of C-Scan, including the company’s upcoming U.S pivotal study.

    Manufacturing Hickups

    Technical issues with a single source supplier resulted in delays in manufacturing, but the company continues to develop and expand its entire production process in order to meet its target manufacturing capacity. Consequently, the company forecasts delays in its clinical trials, at the forefront of which is the U.S. pivotal trial which has an updated commencement date in the first quarter of 2022. The company is continuing to scale its manufacturing up to support the upcoming clinical trials once production returns to normal.

    Future Outlook for CHEK

    Armed with an influx of capital generated from its registered direct offering, CHEK is poised to initiate clinical trials that the company hopes to see through to commercialization. Investors are keen for the company to resume normal manufacturing and allocate resources efficiently, so as to ensure maximum possible growth and increases in shareholder value.

  • 24 stocks making the biggest moves premarket today

    24 stocks making the biggest moves premarket today

    ‎Bionano Genomics Inc. (BNGO) stock soared 55.84% to $4.8 in the pre-‎market trading. The company recently granted 180-day extension by Nasdaq to regain ‎compliance with bid price rule. The most recent rating by Ladenburg Thalmann, on September ‎‎24, 2020, is a Buy.‎

    ‎Jaguar Health Inc. (JAGX) grew over 14.11% at $0.93 in pre-market trading ‎today.‎

    ‎Castor Maritime Inc. (NASDAQ: CTRM) shares are trading up 5.41% at $0.195 ‎at the time of writing after revealing the pricing of $18.0 million registered direct offering. ‎Company’s 52-week ranged between $0.11 to $2.60.‎

    ‎Bit Digital Inc. (BTBT), a Software – Application company, rose about 18.3% at ‎‎$25.92 ‎in pre-market trading Monday.‎

    ‎Canaan Inc. (CAN) stock moved up 18.72 percent to $7.04 in the pre-market ‎trading.‎

    ‎Ebang International Holdings Inc. (EBON) stock soared 25.7% to $7.63 in the ‎pre-market trading after declared that the Company expects to commence public testing of its ‎cryptocurrency exchange and officially launch the exchange in the first quarter of 2021.‎

    ‎Riot Blockchain Inc. (NASDAQ: RIOT) shares are trading up 7.18% at $18.21 ‎at the time of writing. Company’s 52-week ranged between $0.51 to $18.16.‎

    ‎Marathon Patent Group Inc. (MARA) stock moved up 10.92 percent to $11.58 ‎in the pre-market trading following the declaration from the firm that that it has successfully ‎completed its $200 million shelf offering by utilizing its at-the-market (ATM) facility. ‎

    ‎Seanergy Maritime Holdings Corp. (SHIP) lost over -2.7% at $0.5231 in pre-‎market trading Monday January 04, 2021.‎

    ‎Li Auto Inc. (LI) gained over 4.68% at $30.18 in pre-market ‎trading ‎Monday ‎January ‎‎04, 2021 after reporting that the Company delivered 6,126 Li ONEs in ‎December ‎‎2020, ‎representing an ‎increase of 31.9% month-over-month and 529.6% year-over-‎year. ‎

    ‎Gevo Inc. (GEVO) grew over 10.12% at $4.68 in pre-market trading today.‎

    Before the trading started on January 04, 2021, Kinross Gold Corporation ‎‎(KGC) is up 4.9% to reach $7.7. It has been trading in a 52-week range of $2.72 to ‎‎$10.31.‎

    ‎Ocugen Inc. (OCGN), a Biotechnology company, rose about 125.14% at $4.12 ‎in pre-‎‎‎‎market trading Monday.‎

    ‎Color Star Technology Co. Ltd. (CSCW) stock plunged -9.79% to $0.6351 in the ‎pre-market trading. The company recently revealed strategic partnership with two UAE ‎companies. ‎

    ‎Avinger Inc. (AVGR) is up more than 8.16% at $0.476 in pre-market hours ‎Monday ‎January 04, 2021. The stock had dropped over -6.86% to $0.44 in the last trading ‎session.‎

    ‎Harmony Gold Mining Company Limited (HMY) stock soared 9.19% to $5.11 ‎in ‎the ‎pre-market trading. The most recent rating by JP Morgan, on February 21, 2019, is an ‎Overweight.‎

    ‎PEDEVCO Corp. (PED) is down more than -5.3% at $1.43 in pre-‎‎market ‎hours ‎Monday January 04, 2021. The stock had jumped over 20.80% to $1.51 in the last ‎trading ‎session.‎

    ‎Orbital Energy Group Inc. (NASDAQ: OEG) shares are trading up 5.02% at ‎‎$2.3 at ‎the ‎time of writing after pricing $10 million registered direct offering. Company’s 52-‎week ranged ‎between ‎‎$0.45 to $2.80.‎

    ‎Aethlon Medical Inc. (AEMD) is down more than -6.88% at $2.3 in pre-‎market ‎hours ‎Monday January 04, 2021. The stock had jumped over 19.32% to $2.47 in the last ‎trading session.‎

    Before the trading started on January 04, 2021, Invitae Corporation (NVTA) is ‎up 4.31% to reach $43.61. The company recently revealed that Sean George, co-founder and ‎chief executive officer of Invitae, will present at the 39th Annual J.P. Morgan Healthcare ‎Conference on Tuesday, January 12, 2021 at 10:50 a.m. Eastern/7:50 a.m. Pacific. It has been ‎trading in a 52-week range of $7.41 to $61.59.‎

    ‎Hall of Fame Resort & Entertainment Company (HOFV), a ‎Entertainment ‎company, ‎rose about 31.71% at $1.62 in pre-market trading Monday.‎

    ‎T2 Biosystems Inc. (TTOO) is down more than -3.23% at $1.2 in pre-‎market ‎hours ‎Monday January 04, 2021. The stock had dropped over -0.80% to $1.24 in the last ‎trading session.‎

    ‎Clearside Biomedical Inc. (NASDAQ: CLSD) shares are trading up 7.66% ‎at ‎‎$2.95 ‎at ‎the time of writing. Company’s 52-week ranged between $1.10 to $4.13. Analysts ‎have ‎a ‎consensus ‎price target of $8.‎

    ‎Teligent Inc. (NASDAQ: TLGT) shares are trading down -5.13% at $0.7115 at ‎the time of writing after declaring its financial results for the third quarter ended September ‎‎30, 2020. Company’s 52-week ranged between $0.46 to $6.46. Analysts have a consensus price ‎target of $2.‎

  • Pre-Market Cues: 29 Stocks Roaring for Change On December 24th

    Pre-Market Cues: 29 Stocks Roaring for Change On December 24th

    ‎Ocugen Inc. (OCGN) stock plunged -8.85% to $2.37 in the pre-market trading after ‎reporting the appointment of a vaccine scientific advisory board comprised of leading academic and ‎industry experts in the vaccine field.‎

    ‎Sundial Growers Inc. (SNDL), a Drug Manufacturers – Specialty & Generic ‎company, ‎dropped about -3.24% at $0.4838 in pre-market trading Thursday.‎

    ‎Jaguar Health Inc. (NASDAQ: JAGX) shares are trading down -22.43% at $0.83 at the ‎time of writing after signing second agreement for $6 million non-dilutive financing transaction ‎involving the sale of royalty rights related to future Mytesi (Crofelemer) and Lechlemer revenue ‎Sstream. Company’s 52-week ranged between $0.19 to $1.08. Analysts have a consensus price target ‎of $2. ‎

    ‎Onconova Therapeutics Inc. (ONTX) stock moved down -7.92 percent to ‎‎$0.465 ‎in ‎the pre-market trading.‎

    ‎Acasti Pharma Inc. (ACST) tumbled over -4.77% at $0.4095 in pre-market trading ‎today following the announcement from the company that the Company’s management and Board of ‎Directors are unaware of any material change in the Company’s operations that would account for the ‎recent increase in market activity.‎

    ‎FuelCell Energy Inc. (FCEL) lost over -4.55% at $12.81 in pre-‎market ‎trading ‎Thursday ‎December 24, 2020.‎

    ‎Bionano Genomics Inc. (NASDAQ: BNGO) shares are trading down -3.87% at $0.745 ‎at the time of writing after the company announced publication revealing in side-by-side comparison ‎that method using PacBio sequencing ‎detects only 72% of the large structural variants detected by ‎optical Genome Mapping with Saphyr.‎ Company’s 52-week ranged between $0.25 to $1.39. Analysts ‎have a consensus price target of $1.25. ‎

    ‎Marathon Patent Group Inc. (NASDAQ: MARA) shares are trading ‎up ‎‎7.31% ‎at ‎‎$11.6 ‎at the time of writing. Company’s 52-week ranged between $0.35 to ‎‎$14.08. ‎Analysts ‎have ‎a ‎consensus price target of $7.50.‎

    ‎Zomedica Corp. (ZOM) is down more than -2.48% at $0.22 in pre-‎‎‎market ‎hours ‎Thursday December 24, 2020. The stock had jumped over 17.50% to $0.23 in ‎the ‎last ‎trading ‎session.‎

    ‎Nano Dimension Ltd. (NNDM) is up more than 7.18% at $9.4 in pre-‎‎market ‎hours ‎Thursday December 24, 2020. The stock had dropped over -3.41% to $8.77 in the ‎last ‎trading ‎session.‎

    Before the trading started on December 24, 2020, Senseonics Holdings Inc. (SENS) is ‎up 79.29% to reach $1.16 following its declaration of financial and operational business updates. It has ‎been trading in a 52-week range of $0.35 to $1.78.‎

    ‎Corbus Pharmaceuticals Holdings Inc. (CRBP) lost over -2.08% at $1.41 in pre-‎‎market ‎trading Thursday December 24, 2020.‎

    Before the trading started on December 24, 2020, Foresight Autonomous ‎Holdings ‎Ltd. ‎‎(FRSX) is down -20.87% to reach $4.55. It has been trading in a 52-week range ‎of $0.46 ‎to ‎‎$3.40.‎

    ‎Canaan Inc. (CAN) is up more than 2.12% at $3.85 in pre-‎market ‎hours ‎Thursday ‎December 24, 2020. The stock had dropped over -8.94% to $3.77 in the last ‎trading ‎session.‎

    ‎Avinger Inc. (AVGR) stock soared 76.25% to $0.61 in the pre-market trading after ‎reporting results of its annual meeting of stockholders. The most recent rating by Ladenburg ‎Thalmann, on March 09, 2018, is a Buy.‎

    ‎Triterras Inc. (NASDAQ: TRIT) shares are trading up 16.58% at $14.06 ‎at ‎the ‎time ‎of ‎writing. Company’s 52-week ranged between $7.70 to $15.17. Analysts have ‎a ‎consensus ‎price ‎target ‎of $23.‎

    ‎Tantech Holdings Ltd (TANH), a Household & Personal Products ‎company, ‎rose ‎about 3.29% at $1.57 in pre-market trading Thursday.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) grew over 36.36% at $0.9 in pre-market ‎trading today following the announcement from the firm that it has completed the purchase of an ‎approximately 44-acre site in Hamilton, Montana, for the construction of a vaccine development and ‎commercial scale manufacturing facility. ‎

    ‎Gold Resource Corporation (GORO) stock moved down -6.85 percent to ‎‎$3.4 ‎in ‎the ‎pre-market trading.‎

    ‎Nikola Corporation (NKLA) gained over 1.8% at $15.3 in pre-market trading ‎Thursday December 24, 2020. The company reported, on Wednesday, that Nikola and Republic ‎Services (RSG) have discontinued their collaboration on refuse truck development.‎

    ‎Molecular Data Inc. (MKD) gained over 2.94% at $0.9027 in pre-‎‎‎market ‎trading ‎Thursday December 24, 2020.‎

    ‎Gevo Inc. (GEVO), a Specialty Chemicals company, rose about 1.03% at $2.94 in pre-‎‎‎‎‎‎market trading Thursday.‎

    ‎IZEA Worldwide Inc. (NASDAQ: IZEA) shares are trading up 3.9% at $1.6 at the time ‎of writing after reporting that it has set a Managed Services bookings record for the best Q4 in ‎company history. Company’s 52-week ranged between $0.07 to $3.13. IZEA Managed Services ‎Bookings Top 40% Growth in Q4 to Hit Record.‎

    ‎Novan Inc. (NOVN) grew over 6.81% at $0.737 in pre-market trading today.‎

    Before the trading started on December 24, 2020, ReWalk Robotics Ltd. (RWLK) is ‎up 9.2% to reach $1.9. The firm recently revealed that it has donated one of its ReStore Exo-suits to ‎Brooks Rehabilitation, located in Jacksonville, Florida. It has been trading in a 52-week range of $0.41 to ‎‎$2.71.‎

    ‎Inuvo Inc. (AMEX: INUV) shares are trading up 2.16% at $0.52 at the ‎time ‎of ‎writing. ‎Company’s 52-week ranged between $0.09 to $1.11. Analysts have a consensus price ‎target ‎of ‎‎$2.25.‎

    ‎Aurora Mobile Limited (JG) stock soared 8.16% to $4.11 in the pre-market trading ‎following the announcement of a partnership deal with Taikang Life Insurance Co., Ltd., to strengthen ‎smart insurance solutions with AI rechnologies. The most recent rating by Goldman, on March 06, ‎‎2019, is a Neutral.‎

    ‎fuboTV Inc. (FUBO) stock soared 3.73% to $54.55 in the pre-market ‎trading. ‎The ‎most recent rating by BMO Capital Markets, on December 23, 2020, is a Market perform.‎

    ‎Farmmi Inc. (FAMI) is down more than -2.61% at $1.12 in pre-market hours ‎Thursday December 24, 2020. The company recently revealed its sales win to multi-channel ‎customers with over 100 retail stores in China and Canada. The stock had jumped over 1.77% to $1.15 ‎in the last trading session.‎